T.O.4 Development of AAV-gene and protein-based therapies for X-linked myotubular myopathy

MLA

D. Armstrong, et al. T.O.4 Development of AAV-Gene and Protein-Based Therapies for X-Linked Myotubular Myopathy. Oct. 2012. EBSCOhost, https://doi.org/10.1016/J.NMD.2012.06.341⟩.

APA

D. Armstrong, J. Barber, Carole Masurier, Erin Mitchell, M.N. Holder, Melissa A. Goddard, Jeffrey J. Widrick, Philippe Moullier, Nadia Messaddeq, Anna Buj-Bello, Alan H. Beggs, Christopher R. Pierson, R. Joubert, Karine Poulard, T. Soker, Michael W. Lawlor, T. Jamet, Marissa G. Viola, Mark E. Furth, … Alban Vignaud. (2012). T.O.4 Development of AAV-gene and protein-based therapies for X-linked myotubular myopathy. https://doi.org/10.1016/J.NMD.2012.06.341⟩

Chicago

D. Armstrong, J. Barber, Carole Masurier, Erin Mitchell, M.N. Holder, Melissa A. Goddard, Jeffrey J. Widrick, et al. 2012. “T.O.4 Development of AAV-Gene and Protein-Based Therapies for X-Linked Myotubular Myopathy,” October. doi:10.1016/J.NMD.2012.06.341⟩.